Survey of response to co- treatment of single dose fluconazole with vaginal lactobacillus in diabetic patients with vaginal candidiasis
Phase 3
- Conditions
- Candidal Vulvovaginitis.Candidiasis of vulva and vagina
- Registration Number
- IRCT20180612040071N1
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 130
Inclusion Criteria
married women aged 18-45 years old
non pregnant
diabetic
no diagnosed medical disease such as auto immune diseases, by asking the patient
diagnosis of candidal vulvovaginitis by clinical symptoms, positive KOH test and cultivation
absence of menstruation at the time of attendance
not using vaginal medications, antibiotics , immonosupressive drugs and exogenous hormones such as oral contraceptives since 2 weeks before starting the research
not having intercourse or using vaginal douche within the last 24 hours
Exclusion Criteria
allergic reactions to fluconazole or lacto flora fem
pregnancy during therapy
use antibiotics or other anti fungal drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vaginal candidiasis symptoms. Timepoint: 1 month (30dayes ) after the use of probiotics or placebo. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method